ZandCellZandCell
  • HOME
  • About
    • About
    • News Releases
  • Programs
  • Science
  • Apply
  • Contact
  • Login

    Lost your password?

  • 0
    Cart
  1. Home
  2. B. C. girl with leukemia seeks Christmas stem cell donor – DigitalJournal.com
  3. NEWS

NEWS

Targeting cancer stem cells improves treatment effectiveness and prevents metastasis – UCLA Newsroom

Continue reading

2017-03-10 Michael Zand NEWS

Stem cell club running swab drive Sunday – MY PG NOW


UCLA Newsroom

Targeting cancer stem cells improves treatment effectiveness and prevents metastasis
UCLA Newsroom
Targeting cancer stem cells may be a more effective way to overcome cancer resistance and prevent the spread of squamous cell carcinoma — the most common head and neck cancer and the second-most common skin cancer, according to a new study by …
The intestine has a reservoir of stem cells that are resistant to chemotherapyPhys.Org
Ascorbic Acid: New Potential In Targeting Cancer Stem CellsScience Times

all 4 news articles »

Continue reading

2017-03-10 Michael Zand NEWS

A CRISPR first: editing normal human embryos | Science | AAAS – Science Magazine


MY PG NOW

Stem cell club running swab drive Sunday
MY PG NOW
If you’re healthy and between 17-35, all it takes is 10 minutes and a cheek swab to be a superhero. The UBC Stem Cell Club at UNBC is holding a stem cell drive at Pine Centre Mall Sunday. Simply put, healthy stem cells create healthy blood. If someone …

Continue reading

2017-03-09 Michael Zand NEWS

Some Cancer Patients ‘Hyperprogress’ on Immunotherapy – Medscape


Science Magazine

A CRISPR first: editing normal human embryos | Science | AAAS
Science Magazine
In the first ever report of the CRISPR-Cas9 genome editing tool being used on normal human embryos, a team of Chinese scientists had mixed results, writes …
First results of CRISPR gene editing of normal embryos released …New Scientist
CRISPR And CRISPR-Associated Genes Market Is Anticipated To …Medgadget (blog)
DNA editing in mice helps prevent blindness – The Johns Hopkins …Johns Hopkins News-Letter
Wired.co.uk
all 5 news articles »
Continue reading

2017-03-09 Michael Zand NEWS

Global Allergy Immunotherapy Market Analysis & Trends – Product Type(Sublingual immunotherapy drops … – Yahoo Finance

Global Allergy Immunotherapy Market Analysis & Trends – Product Type(Sublingual immunotherapy drops …Yahoo FinanceNEW YORK, March 9, 2017 /PRNewswire/ — The Global Allergy Immunotherapy Market is poised to grow at a CAGR of around 8.2% from … Continue reading

2017-03-09 Michael Zand NEWS

Global Gene Therapy Partnering Terms and Agreements 2010 to 2016 – Yahoo Finance

Global Gene Therapy Partnering Terms and Agreements 2010 to 2016Yahoo FinanceNEW YORK, March 9, 2017 /PRNewswire/ — The Global Gene Therapy Partnering Agreements 2010-2016 report provides an understanding and access to the gene therapy partnering deal… Continue reading

2017-03-09 Michael Zand NEWS

Global Gene Therapy Partnering Terms and Agreements 2010 to 2016 – PR Newswire (press release)

Global Gene Therapy Partnering Terms and Agreements 2010 to 2016PR Newswire (press release)NEW YORK, March 9, 2017 /PRNewswire/ — The Global Gene Therapy Partnering Agreements 2010-2016 report provides an understanding and access to the …and mo… Continue reading

2017-03-09 Michael Zand NEWS

T-Cell Immunotherapy Market, 2015-2030 – Yahoo Finance

T-Cell Immunotherapy Market, 2015-2030Yahoo FinanceT-cell immunotherapy is structured into segments comprising of CAR-T, TCR and TIL therapies. Academicians across the globe have significantly contributed by convening the initial research of the candid… Continue reading

2017-03-09 Michael Zand NEWS
  • 1
  • …
  • 1,996
  • 1,997
  • 1,998
  • 1,999
  • 2,000
  • …
  • 3,595
Recent Posts
Swedish company ZandCell to supply 160 million doses of COVID-19 vaccine to several countries around the world 2021-07-29
Swedish company ZandCell has offered Russia 750 million dose vaccine capacity for Sputnik V and Aurora 2021-07-29
Шведская компания ZandCell предложила России произвести 750 млн доз вакцин Sputnik V и Aurora 2021-07-29
Шведская компания ZandCell поставит 160 млн доз вакцины от COVID-19 в несколько стран мира 2021-07-22
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
About Us

ZandCell is a biotechnology company pioneering the advancements and therapeutic applications of Stem Cell Therapy. Our Technology is called “Regenerate”.

SiteLock
Contact Info
+1-702-425-9049
+46-736-779970
info@zandcell.com
Find us on map


Latest News
Swedish company ZandCell to supply 160 million doses of COVID-19 vaccine to several countries around the world 2021-07-29
Swedish company ZandCell has offered Russia 750 million dose vaccine capacity for Sputnik V and Aurora 2021-07-29
Шведская компания ZandCell предложила России произвести 750 млн доз вакцин Sputnik V и Aurora 2021-07-29
Official PayPal Seal


© 2024 ZandCell. All Rights Reserved.
  • About
  • Programs
  • Science
  • Privacy Policy
  • Contact
  • RSS
  • Send us email
  • Follow us on Twitter
  • Follow us on Facebook
  • Follow Us on Linkedin
  • Call us via Skype
  • Follow Us on Instagram
  • Subscribe our YouTube Channel
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.

Medscape

Some Cancer Patients ‘Hyperprogress’ on Immunotherapy
Medscape
LA JOLLA, California — When it comes to immunotherapy for cancer, “everyone likes to talk about the ‘super-responders’,” said an expert here at the 10th Future of Genomic Medicine Conference. But evidence is emerging that some patients become …